D. Shouval Et Al. , "Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: The case for continuous antiviral therapy," JOURNAL OF HEPATOLOGY , vol.50, no.2, pp.289-295, 2009
Shouval, D. Et Al. 2009. Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: The case for continuous antiviral therapy. JOURNAL OF HEPATOLOGY , vol.50, no.2 , 289-295.
Shouval, D., Lai, C., Chang, T., Cheinquer, H., Martin, P., Carosi, G., ... Han, S.(2009). Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: The case for continuous antiviral therapy. JOURNAL OF HEPATOLOGY , vol.50, no.2, 289-295.
Shouval, Daniel Et Al. "Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: The case for continuous antiviral therapy," JOURNAL OF HEPATOLOGY , vol.50, no.2, 289-295, 2009
Shouval, Daniel Et Al. "Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: The case for continuous antiviral therapy." JOURNAL OF HEPATOLOGY , vol.50, no.2, pp.289-295, 2009
Shouval, D. Et Al. (2009) . "Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: The case for continuous antiviral therapy." JOURNAL OF HEPATOLOGY , vol.50, no.2, pp.289-295.
@article{article, author={Daniel Shouval Et Al. }, title={Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: The case for continuous antiviral therapy}, journal={JOURNAL OF HEPATOLOGY}, year=2009, pages={289-295} }